Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Preclinical, clinical results for CC-5013 in multiple myeloma and myelodysplastic syndromes reported

Dec. 20, 2004

Serono and CancerVax form global collaboration for Canvaxin

Dec. 20, 2004

HuMax-CD20 receives fast track designation in CLL

Dec. 20, 2004

Aphton to acquire Igeneon

Dec. 17, 2004

Antibody therapy may enhance rituximab-mediated killing in non-Hodgkin's lymphoma

Dec. 17, 2004

Toll-like receptor agonist may be an effective immunotherapeutic approach to CLL

Dec. 17, 2004

Update on the efficacy and safety of MDX-060 in CD30-positive lymphoma

Dec. 16, 2004

Good tolerability profile found for DT388-IL-3 in AML

Dec. 16, 2004

FTC requests extension for review of MDX-010 collaboration

Dec. 14, 2004

First phase I/II data on the efficacy and safety of HuMax-CD20 in follicular lymphoma

Dec. 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...